Gemphire Therapeutics Inc buy melinda
Start price
23.10.17
/
50%
?221.67
Target price
26.12.17
€248.05
Performance (%)
-16.79%
End price
26.12.17
€184.46
Summary
This prediction ended on 26.12.17 with a price of €184.46. The prediction for Gemphire Therapeutics Inc disappointed with a performance of -16.79%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gemphire Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 1.663% | 6.945% | 18.807% | 17.549% |
iShares Nasdaq 100 | 1.261% | 4.883% | 23.667% | 36.206% |
iShares Nikkei 225® | 0.654% | 10.007% | 15.047% | 9.552% |
iShares S&P 500 | 1.403% | 4.350% | 23.305% | 38.641% |
Comments by melinda for this prediction
In the thread Gemphire Therapeutics Inc diskutieren
Biotechnologie und medizinische SecteurRecherche
Positive Ergebnisse aus einer präklinischen Studie in Gemcabene NASH an der Leber Meeting® 2017 vorbestellt präsentiert
(Vom Mitglied beendet)
Stopped prediction by melinda for Gemphire Therapeutics Inc
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?27.75
14.11.18
14.11.18
€31.57
04.12.18
04.12.18
12.14%
04.12.18
04.12.18
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?245.75
23.10.17
23.10.17
€275.00
26.12.17
26.12.17
-16.79%
26.12.17
26.12.17
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?293.83
29.06.17
29.06.17
€383.35
18.07.17
18.07.17
24.92%
18.07.17
18.07.17
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?325.75
29.06.17
29.06.17
€425.00
18.07.17
18.07.17
24.92%
18.07.17
18.07.17